Moderate

Chronic cor pulmonale

right heart from lung disease · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Cor pulmonale is right ventricular dysfunction secondary to chronic lung disease and pulmonary hypertension (most often COPD-related hypoxic pulmonary vasoconstriction). Management centres on treating the underlying lung disease, correcting hypoxaemia and cautious diuresis.

Red flags

  • Hypotension / low cardiac output
  • Worsening hypoxaemia or hypercapnia
  • Syncope
  • Massive fluid overload with hepatic congestion

Assessment

Differential diagnosis

  • Left heart failure
  • Group 1 pulmonary arterial hypertension
  • Chronic thromboembolic pulmonary hypertension
  • Valvular heart disease
  • Constrictive pericarditis

Investigations

  • Echocardiography (RV dilatation/dysfunction, estimated PA pressure)
  • Arterial blood gases (hypoxaemia +/- hypercapnia)
  • ECG (right-axis deviation, P pulmonale, RV strain)
  • BNP/NT-proBNP
  • Lung function, HRCT and sleep study for underlying disease; exclude CTEPH with V/Q scan

Management

  • Confirm right heart dysfunction and estimate pulmonary pressures with echocardiography
  • Identify and optimise the underlying lung disease (COPD, ILD, OSA, hypoventilation)
  • Correct chronic hypoxaemia with long-term oxygen therapy where criteria are met
  • Exclude chronic thromboembolic disease with a V/Q scan
  • Treat nocturnal hypoventilation/OSA with NIV/CPAP as indicated
  • Use diuretics cautiously for peripheral oedema, avoiding over-diuresis and hypotension
  • Avoid routine PAH-specific vasodilators in group 3 disease (risk of worsening gas exchange)
  • Manage arrhythmia and secondary polycythaemia
  • Provide pulmonary rehabilitation and vaccination
  • Monitor and set ceilings of care; consider transplant for selected end-stage disease

Drugs & doses

Oxygen (LTOT) to correct chronic hypoxaemia — the key disease-modifying therapy
Furosemide 20-40 mg PO/IV titrated for oedema (cautious diuresis)
Optimise bronchodilators for COPD; NIV for hypoventilation
Avoid routine pulmonary vasodilators in group 3 PH

Disposition

Respiratory clinic with LTOT and NIV services; pulmonary hypertension centre if disproportionate PH; palliative care for end-stage disease.

Complications & pitfalls

  • Progressive right heart failure
  • Arrhythmia
  • Hepatic/renal congestion
  • Secondary polycythaemia and thrombosis

Exam pearls

  • Correcting hypoxaemia with long-term oxygen is the main therapy that improves survival in COPD cor pulmonale
  • Over-diuresis reduces preload and cardiac output in a preload-dependent right ventricle — be cautious
  • PAH vasodilators can worsen oxygenation in lung-disease-related PH — avoid routinely
  • Always exclude CTEPH, which is treatable, before attributing PH to the lung disease

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.